rxstat › Classes › Hormonal Contraceptives For Systemic Use

Hormonal Contraceptives For Systemic Use: shortage status in Canada

6 of the 13 hormonal contraceptives for systemic use rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Drospirenone Ethinyl Estradiol (Zamine) Partial shortage 2 of 9 reported products affected · est. return Jul 31, 2026 Ethinyl Estradiol Desogestrel (Reclipsen) Partial shortage 1 of 10 reported products affected · est. return Aug 20, 2026 Ethinyl Estradiol Levonorgestrel (Portia) Partial shortage 3 of 18 reported products affected Ethinyl Estradiol Levonorgestrel (Seasonique) Partial shortage 1 of 1 reported products affected Ethinyl Estradiol Norethindrone (Ortho) Partial shortage 4 of 10 reported products affected · est. return Mar 19, 2027 Norethindrone (Movisse) Partial shortage 1 of 4 reported products affected Ethinyl Estradiol Ethynodiol Diacetate (Demulen) Discontinued 0 of 2 reported products affected Ethinyl Estradiol Norethindrone (Ortho) Discontinued 0 of 2 reported products affected Ethinyl Estradiol Norgestimate (Cyclen) Discontinued 0 of 2 reported products affected Levomefolate Drospirenone Ethinyl Estradiol (Yaz Plus) No current shortage Levonorgestrel (Jaydess) No current shortage Norethindrone Ethinyl Estradiol (Synphasic) Discontinued 0 of 2 reported products affected Ulipristal (Fibristal) No current shortage

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.